Cited by 93Sperm and Testicular FunctionHormonal and reproductive studiesHypothalamic control of reproductive hormones

Changes in hormonal profile and seminal parameters with use of aromatase inhibitors in management of infertile men with low testosterone to estradiol ratios

Open access
Gregoriou, Odysseas, Bakas, Panagiotis, Grigoriadis, Charalampos, Creatsa, Maria, Hassiakos, Dimitrios, Creatsas, Georgios·2012·Fertility and Sterility

Abstract

Objective To compare the effects of 2.5 mg letrozole with those of 1 mg anastrazole daily on the hormonal and semen profiles of a subset of infertile men with low T/E(2) ratios. Design Prospective, nonrandomized study. Setting Reproductive medicine clinic. Patient(s) The study group consisted of 29 infertile men with a low serum T/E(2) ratio (<10). Intervention(s) Patients were divided into two groups. Group A included 15 patients treated with 2.5 mg letrozole orally once daily for 6 months, and Group B consisted of 14 patients treated with 1 mg anastrazole orally every day for 6 months. Main outcome measure(s) Hormonal evaluation included measurement of serum FSH, LH, PRL, T, and E(2). In all sperm analyses pretreatment and posttreatment total motile sperm counts (ejaculate volume × concentration × motile fraction) were evaluated. Result(s) The use of aromatase inhibitors (either letrozole or anastrazole) in cases of infertile men with low T/E(2) ratios improved both hormonal and semen parameters. Conclusion(s) This study suggests that some men with severe oligospermia, low T levels, and normal gonadotropin concentration may have a treatable endocrinopathy.

Integrity signals

Registry

Crossref · 10.1016/j.fertnstert.2012.04.005

Cites

6 of 6 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Gregoriou, O., Bakas, P., Grigoriadis, C., Creatsa, M., Hassiakos, D., & Creatsas, G.
Affiliations
National and Kapodistrian University of Athens (GR)
Venue
Fertility and Sterility
Publisher
Elsevier BV
Published
2012-07
Volume
98
Issue
1
Pages
48-51
ISSN
0015-0282 (ISSN-L)
OpenAlex
W1978134855
Cited by
93
References
6
Citations by year
2026: 2 · 2025: 5 · 2024: 12 · 2023: 9 · 2022: 13 · 2021: 6 · 2020: 5 · 2019: 4 · 2018: 9 · 2017: 5 · 2016: 7 · 2015: 5 · 2014: 3 · 2013: 5 · 2012: 2
FWCI
5.57
Type
journal article
Language
en
Open access
Locations
  • Fertility and Sterility (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Reproductive Medicine › Sperm and Testicular Function
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hormonal and reproductive studies
  • Health Sciences › Medicine › Reproductive Medicine › Hypothalamic control of reproductive hormones
Keywords
aromatase inhibitors, letrozole, anastrozole, male infertility, oligozoospermia, semen parameters, sperm motility, gonadotropins, endocrine disorders, hypogonadism
MeSH terms
Letrozole, Anastrozole, Adult, Estradiol, Hormones, Humans, Infertility, Male, Male, Nitriles, Organ Size, Testis, Testosterone, Triazoles, Aromatase Inhibitors, Semen Analysis

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review